Saturday, October 31, 2026

Sierra Bancorp And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

December 28, 2020

Sierra Bancorp And 3 Other Stocks Have Very High Payout Ratio

We have congregated information about stocks with the highest payout ratio up until now. The payout ratio in itself isn't a guarantee of good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know and anything around 60 percent is considered high.

1. Sociedad Quimica y Minera S.A.

111.69% Payout Ratio

Sociedad Química y Minera de Chile S.A. produces and distributes specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, potassium chloride and sulfate, industrial chemicals, and other products and services.

As maintained by Morningstar, Inc., the next dividend payment is on Oct 7, 2020, the estimated forward annual dividend rate is 0.71 and the estimated forward annual dividend yield is 1.5%.

Sociedad Quimica y Minera S.A.'s sales growth this year is anticipated to be negative 7.9% and 19.5% for next year.

Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 1.78B for the twelve trailing months.

Sociedad Quimica y Minera S.A.'s sales growth is negative 4% for the ongoing quarter and negative 5% for the next. The company's growth estimates for the current quarter and the next is negative 8.7% and negative -20%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.95%.

Sociedad Quimica y Minera S.A.'s Stock Yearly Top and Bottom Value

Sociedad Quimica y Minera S.A.'s stock is valued at $47.25 at 19:23 EST, under its 52-week high of $48.67 and way higher than its 52-week low of $15.20.

Sociedad Quimica y Minera S.A.'s Moving Average

Sociedad Quimica y Minera S.A.'s value is above its 50-day moving average of $44.90 and way above its 200-day moving average of $34.60.

2. PotlatchDeltic Corporation

137.93% Payout Ratio

PotlatchDeltic (NASDAQ:PCH) is a leading Real Estate Investment Trust (REIT) that owns nearly 1.8 million acres of timberlands in Alabama, Arkansas, Idaho, Louisiana, Minnesota and Mississippi.

As claimed by Morningstar, Inc., the next dividend payment is on Dec 13, 2020, the estimated forward annual dividend rate is 1.64 and the estimated forward annual dividend yield is 3.24%.

PotlatchDeltic Corporation's sales growth this year is expected to be 23.7% and a negative 3.3% for next year.

Year-on-year quarterly revenue growth grew by 38.3%, now sitting on 906.98M for the twelve trailing months.

PotlatchDeltic Corporation's sales growth is 57.1% for the ongoing present quarter and 11.1% for the next. The company's growth estimates for the current quarter and the next is 363.3% and 280%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.43%.

PotlatchDeltic Corporation's Stock Yearly Top and Bottom Value

PotlatchDeltic Corporation's stock is valued at $50.65 at 19:23 EST, under its 52-week high of $51.68 and way above its 52-week low of $22.40.

PotlatchDeltic Corporation's Moving Average

PotlatchDeltic Corporation's value is way above its 50-day moving average of $45.86 and way above its 200-day moving average of $43.21.

3. Sierra Bancorp

33.91% Payout Ratio

Sierra Bancorp operates as the bank holding company for Bank of the Sierra that provides retail and commercial banking services to individuals and businesses in California.

According to Morningstar, Inc., the next dividend payment is on Oct 28, 2020, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 3.34%.

Sierra Bancorp's sales growth this year is expected to be 8% and 4.2% for next year.

Year-on-year quarterly revenue growth grew by 13.6%, now sitting on 119.93M for the twelve trailing months.

Sierra Bancorp's sales growth is negative 3.5% for the ongoing quarter and 13.4% for the next. The company's growth estimates for the current quarter and the next is 1.7% and 15.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.18%.

Sierra Bancorp's Stock Yearly Top and Bottom Value

Sierra Bancorp's stock is valued at $23.63 at 19:23 EST, way under its 52-week high of $30.07 and way higher than its 52-week low of $13.05.

Sierra Bancorp's Moving Average

Sierra Bancorp's worth is above its 50-day moving average of $22.57 and way above its 200-day moving average of $19.27.

4. AEGON N.V.

35.78% Payout Ratio

Aegon N.V. provides insurance, pensions, and asset management services in the Americas, Europe, and Asia.

As stated by Morningstar, Inc., the next dividend payment is on Aug 20, 2020, the estimated forward annual dividend rate is 0.14 and the estimated forward annual dividend yield is 3.72%.

AEGON N.V.'s sales growth this year is expected to be negative 0% and a negative 0% for next year.

Year-on-year quarterly revenue growth declined by 73%, now sitting on N/A for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.7%.

AEGON N.V.'s Stock Yearly Top and Bottom Value

AEGON N.V.'s stock is valued at $3.72 at 19:23 EST, way below its 52-week high of $4.61 and way above its 52-week low of $1.80.

AEGON N.V.'s Moving Average

AEGON N.V.'s value is higher than its 50-day moving average of $3.45 and way above its 200-day moving average of $3.04.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com